These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 2511221)

  • 1. Increased growth hormone pulse frequency in acromegaly.
    Barkan AL; Stred SE; Reno K; Markovs M; Hopwood NJ; Kelch RP; Beitins IZ
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1225-33. PubMed ID: 2511221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
    Gelato MC; Oldfield E; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors.
    Ho PJ; Jaffe CA; Friberg RD; Chandler WF; Barkan AL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1403-10. PubMed ID: 7911124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with acromegaly.
    Ho PJ; Friberg RD; Barkan AL
    J Clin Endocrinol Metab; 1992 Sep; 75(3):812-9. PubMed ID: 1517371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone-releasing hormone infusion in patients with active acromegaly.
    Losa M; Chiodini PG; Liuzzi A; König A; Müller OA; Schopohl J; von Werder K
    J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pulsatile GH secretion in acromegaly: hypothalamic or pituitary origin?
    Riedel M; Günther T; von zur Mühlen A; Brabant G
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):233-9. PubMed ID: 1358484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sumatriptan on growth hormone releasing hormone-stimulated growth hormone secretion in acromegaly.
    Cuttica CM; Sessarego P; Ponzani P; Falivene MR; Valenti S; De Martini D; Giusti M
    Recenti Prog Med; 1997 Jun; 88(6):264-8. PubMed ID: 9233053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release.
    Hartman ML; Pincus SM; Johnson ML; Matthews DH; Faunt LM; Vance ML; Thorner MO; Veldhuis JD
    J Clin Invest; 1994 Sep; 94(3):1277-88. PubMed ID: 8083369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion.
    Moller DE; Moses AC; Jones K; Thorner MO; Vance ML
    J Clin Endocrinol Metab; 1989 Feb; 68(2):499-504. PubMed ID: 2493033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly.
    Spada A; Elahi FR; Arosio M; Sartorio A; Guglielmino L; Vallar L; Faglia G
    J Clin Endocrinol Metab; 1987 Mar; 64(3):585-91. PubMed ID: 3102543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy.
    Hartman ML; Veldhuis JD; Vance ML; Faria AC; Furlanetto RW; Thorner MO
    J Clin Endocrinol Metab; 1990 May; 70(5):1375-84. PubMed ID: 2335577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in acromegaly and type I diabetes mellitus.
    Pietschmann P; Schernthaner G; Luger A
    J Clin Endocrinol Metab; 1986 Aug; 63(2):389-93. PubMed ID: 3088023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients.
    van der Klaauw AA; Pereira AM; van Thiel SW; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):489-98. PubMed ID: 17371464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
    Kelijman M; Williams TC; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone pulsatility in active and cured acromegalic subjects.
    Semer M; Faria AC; Nery M; Salgado LR; Knoepfelmacher M; Wajchenberg BL; Liberman B
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3767-70. PubMed ID: 8530632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.